カテゴリー： 世界, 医療/バイオ, LP Information

世界の副甲状腺及び関連医薬品市場予測 2023年-2029年

【英語タイトル】Global Parathyroid Glands and Related Medicines Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02777）・商品コード：LP23DC02777
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の副甲状腺及び関連医薬品市場」は、過去の販売実績から2022年の世界の副甲状腺及び関連医薬品の総販売量を検討し、2023年から2029年の予測される副甲状腺及び関連医薬品の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の副甲状腺及び関連医薬品の市場規模を掲載し、XXX百万米ドル規模の世界の副甲状腺及び関連医薬品市場の詳細な分析を提供します。本インサイトレポートは、世界の副甲状腺及び関連医薬品業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の副甲状腺及び関連医薬品市場における各社の独自のポジションをより深く理解するために、副甲状腺及び関連医薬品製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の副甲状腺及び関連医薬品市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。副甲状腺及び関連医薬品の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。副甲状腺及び関連医薬品の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。副甲状腺及び関連医薬品のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

副甲状腺及び関連医薬品の世界主要メーカーとしては、CTTQ、 Roche、 Future Health Pharma、 KPC Pharmaceuticals、 Teva Pharmaceutical、 Nantong Huashan Pharmaceutical、 Teijin Pharma、 Kyowa Kirin、 Cheplapharm Arzneimittel、 Jiangsu Hengrui Pharmaceuticals、 Novartis、 Chongqing Yaoyou Pharmaceutical、 AbbVie、 Hebei Renhe Yikang Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の副甲状腺及び関連医薬品市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では副甲状腺及び関連医薬品市場をセグメンテーションし、種類別 (カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の副甲状腺及び関連医薬品市場の10年間の市場状況・展望は？
・世界および地域別に見た副甲状腺及び関連医薬品市場成長の要因は何か？
・副甲状腺及び関連医薬品の市場機会はエンドマーケットの規模によってどのように変化するのか？
・副甲状腺及び関連医薬品のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：副甲状腺及び関連医薬品の年間販売量2018-2029、地域別現状・将来分析
・副甲状腺及び関連医薬品の種類別セグメント：カルシトリオール、アルファカルシドール、サケカルシトニン、パリカルシトール、その他
・副甲状腺及び関連医薬品の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・副甲状腺及び関連医薬品の用途別セグメント：病院、診療所、その他
・副甲状腺及び関連医薬品の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の副甲状腺及び関連医薬品市場
・企業別のグローバル副甲状腺及び関連医薬品市場データ：2018-2023年の年間販売量、市場シェア
・企業別の副甲状腺及び関連医薬品の年間売上：2018-2023年の売上、市場シェア
・企業別の副甲状腺及び関連医薬品販売価格
・主要企業の副甲状腺及び関連医薬品生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

副甲状腺及び関連医薬品の地域別レビュー
・地域別の副甲状腺及び関連医薬品市場規模2018-2023：年間販売量、売上
・主要国別の副甲状腺及び関連医薬品市場規模2018-2023：年間販売量、売上
・南北アメリカの副甲状腺及び関連医薬品販売の成長
・アジア太平洋の副甲状腺及び関連医薬品販売の成長
・ヨーロッパの副甲状腺及び関連医薬品販売の成長
・中東・アフリカの副甲状腺及び関連医薬品販売の成長

南北アメリカ市場
・南北アメリカの国別の副甲状腺及び関連医薬品販売量、売上（2018-2023）
・南北アメリカの副甲状腺及び関連医薬品の種類別販売量
・南北アメリカの副甲状腺及び関連医薬品の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の副甲状腺及び関連医薬品販売量、売上（2018-2023）
・アジア太平洋の副甲状腺及び関連医薬品の種類別販売量
・アジア太平洋の副甲状腺及び関連医薬品の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の副甲状腺及び関連医薬品販売量、売上（2018-2023）
・ヨーロッパの副甲状腺及び関連医薬品の種類別販売量
・ヨーロッパの副甲状腺及び関連医薬品の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の副甲状腺及び関連医薬品販売量、売上（2018-2023）
・中東・アフリカの副甲状腺及び関連医薬品の種類別販売量
・中東・アフリカの副甲状腺及び関連医薬品の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・副甲状腺及び関連医薬品の製造コスト構造分析
・副甲状腺及び関連医薬品の製造プロセス分析
・副甲状腺及び関連医薬品の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・副甲状腺及び関連医薬品の主要なグローバル販売業者
・副甲状腺及び関連医薬品の主要なグローバル顧客

地域別の副甲状腺及び関連医薬品市場予測レビュー
・地域別の副甲状腺及び関連医薬品市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・副甲状腺及び関連医薬品の種類別市場規模予測
・副甲状腺及び関連医薬品の用途別市場規模予測

主要企業分析
CTTQ、 Roche、 Future Health Pharma、 KPC Pharmaceuticals、 Teva Pharmaceutical、 Nantong Huashan Pharmaceutical、 Teijin Pharma、 Kyowa Kirin、 Cheplapharm Arzneimittel、 Jiangsu Hengrui Pharmaceuticals、 Novartis、 Chongqing Yaoyou Pharmaceutical、 AbbVie、 Hebei Renhe Yikang Pharmaceutical
・企業情報
・副甲状腺及び関連医薬品製品
・副甲状腺及び関連医薬品販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Parathyroid Glands and Related Medicines market size is projected to grow from US$ 1225.7 million in 2022 to US$ 1900.1 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
United States market for Parathyroid Glands and Related Medicines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Parathyroid Glands and Related Medicines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Parathyroid Glands and Related Medicines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Parathyroid Glands and Related Medicines players cover CTTQ, Roche, Future Health Pharma, KPC Pharmaceuticals, Teva Pharmaceutical, Nantong Huashan Pharmaceutical, Teijin Pharma, Kyowa Kirin and Cheplapharm Arzneimittel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The parathyroid glands are four small glands located in the neck that produce parathyroid hormone (PTH), which regulates the levels of calcium and phosphorus in the body. There are several drugs that can affect the function of the parathyroid gland or the levels of PTH in the body.
LPI (LP Information)’ newest research report, the “Parathyroid Glands and Related Medicines Industry Forecast” looks at past sales and reviews total world Parathyroid Glands and Related Medicines sales in 2022, providing a comprehensive analysis by region and market sector of projected Parathyroid Glands and Related Medicines sales for 2023 through 2029. With Parathyroid Glands and Related Medicines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parathyroid Glands and Related Medicines industry.
This Insight Report provides a comprehensive analysis of the global Parathyroid Glands and Related Medicines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parathyroid Glands and Related Medicines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parathyroid Glands and Related Medicines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parathyroid Glands and Related Medicines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parathyroid Glands and Related Medicines.
This report presents a comprehensive overview, market shares, and growth opportunities of Parathyroid Glands and Related Medicines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Calcitriol
Alfacalcidol
Salmon Calcitonin
Paricalcitol
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
CTTQ
Roche
Future Health Pharma
KPC Pharmaceuticals
Teva Pharmaceutical
Nantong Huashan Pharmaceutical
Teijin Pharma
Kyowa Kirin
Cheplapharm Arzneimittel
Jiangsu Hengrui Pharmaceuticals
Novartis
Chongqing Yaoyou Pharmaceutical
AbbVie
Hebei Renhe Yikang Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Parathyroid Glands and Related Medicines market?
What factors are driving Parathyroid Glands and Related Medicines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Parathyroid Glands and Related Medicines market opportunities vary by end market size?
How does Parathyroid Glands and Related Medicines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parathyroid Glands and Related Medicines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Parathyroid Glands and Related Medicines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Parathyroid Glands and Related Medicines by Country/Region, 2018, 2022 & 2029
2.2 Parathyroid Glands and Related Medicines Segment by Type
2.2.1 Calcitriol
2.2.2 Alfacalcidol
2.2.3 Salmon Calcitonin
2.2.4 Paricalcitol
2.2.5 Other
2.3 Parathyroid Glands and Related Medicines Sales by Type
2.3.1 Global Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
2.3.2 Global Parathyroid Glands and Related Medicines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Parathyroid Glands and Related Medicines Sale Price by Type (2018-2023)
2.4 Parathyroid Glands and Related Medicines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Parathyroid Glands and Related Medicines Sales by Application
2.5.1 Global Parathyroid Glands and Related Medicines Sale Market Share by Application (2018-2023)
2.5.2 Global Parathyroid Glands and Related Medicines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Parathyroid Glands and Related Medicines Sale Price by Application (2018-2023)
3 Global Parathyroid Glands and Related Medicines by Company
3.1 Global Parathyroid Glands and Related Medicines Breakdown Data by Company
3.1.1 Global Parathyroid Glands and Related Medicines Annual Sales by Company (2018-2023)
3.1.2 Global Parathyroid Glands and Related Medicines Sales Market Share by Company (2018-2023)
3.2 Global Parathyroid Glands and Related Medicines Annual Revenue by Company (2018-2023)
3.2.1 Global Parathyroid Glands and Related Medicines Revenue by Company (2018-2023)
3.2.2 Global Parathyroid Glands and Related Medicines Revenue Market Share by Company (2018-2023)
3.3 Global Parathyroid Glands and Related Medicines Sale Price by Company
3.4 Key Manufacturers Parathyroid Glands and Related Medicines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parathyroid Glands and Related Medicines Product Location Distribution
3.4.2 Players Parathyroid Glands and Related Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Parathyroid Glands and Related Medicines by Geographic Region
4.1 World Historic Parathyroid Glands and Related Medicines Market Size by Geographic Region (2018-2023)
4.1.1 Global Parathyroid Glands and Related Medicines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Parathyroid Glands and Related Medicines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Parathyroid Glands and Related Medicines Market Size by Country/Region (2018-2023)
4.2.1 Global Parathyroid Glands and Related Medicines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Parathyroid Glands and Related Medicines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Parathyroid Glands and Related Medicines Sales Growth
4.4 APAC Parathyroid Glands and Related Medicines Sales Growth
4.5 Europe Parathyroid Glands and Related Medicines Sales Growth
4.6 Middle East & Africa Parathyroid Glands and Related Medicines Sales Growth
5 Americas
5.1 Americas Parathyroid Glands and Related Medicines Sales by Country
5.1.1 Americas Parathyroid Glands and Related Medicines Sales by Country (2018-2023)
5.1.2 Americas Parathyroid Glands and Related Medicines Revenue by Country (2018-2023)
5.2 Americas Parathyroid Glands and Related Medicines Sales by Type
5.3 Americas Parathyroid Glands and Related Medicines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parathyroid Glands and Related Medicines Sales by Region
6.1.1 APAC Parathyroid Glands and Related Medicines Sales by Region (2018-2023)
6.1.2 APAC Parathyroid Glands and Related Medicines Revenue by Region (2018-2023)
6.2 APAC Parathyroid Glands and Related Medicines Sales by Type
6.3 APAC Parathyroid Glands and Related Medicines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Parathyroid Glands and Related Medicines by Country
7.1.1 Europe Parathyroid Glands and Related Medicines Sales by Country (2018-2023)
7.1.2 Europe Parathyroid Glands and Related Medicines Revenue by Country (2018-2023)
7.2 Europe Parathyroid Glands and Related Medicines Sales by Type
7.3 Europe Parathyroid Glands and Related Medicines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Parathyroid Glands and Related Medicines by Country
8.1.1 Middle East & Africa Parathyroid Glands and Related Medicines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Parathyroid Glands and Related Medicines Revenue by Country (2018-2023)
8.2 Middle East & Africa Parathyroid Glands and Related Medicines Sales by Type
8.3 Middle East & Africa Parathyroid Glands and Related Medicines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parathyroid Glands and Related Medicines
10.3 Manufacturing Process Analysis of Parathyroid Glands and Related Medicines
10.4 Industry Chain Structure of Parathyroid Glands and Related Medicines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parathyroid Glands and Related Medicines Distributors
11.3 Parathyroid Glands and Related Medicines Customer
12 World Forecast Review for Parathyroid Glands and Related Medicines by Geographic Region
12.1 Global Parathyroid Glands and Related Medicines Market Size Forecast by Region
12.1.1 Global Parathyroid Glands and Related Medicines Forecast by Region (2024-2029)
12.1.2 Global Parathyroid Glands and Related Medicines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Parathyroid Glands and Related Medicines Forecast by Type
12.7 Global Parathyroid Glands and Related Medicines Forecast by Application
13 Key Players Analysis
13.1 CTTQ
13.1.1 CTTQ Company Information
13.1.2 CTTQ Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.1.3 CTTQ Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 CTTQ Main Business Overview
13.1.5 CTTQ Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.2.3 Roche Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Future Health Pharma
13.3.1 Future Health Pharma Company Information
13.3.2 Future Health Pharma Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.3.3 Future Health Pharma Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Future Health Pharma Main Business Overview
13.3.5 Future Health Pharma Latest Developments
13.4 KPC Pharmaceuticals
13.4.1 KPC Pharmaceuticals Company Information
13.4.2 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.4.3 KPC Pharmaceuticals Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 KPC Pharmaceuticals Main Business Overview
13.4.5 KPC Pharmaceuticals Latest Developments
13.5 Teva Pharmaceutical
13.5.1 Teva Pharmaceutical Company Information
13.5.2 Teva Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Teva Pharmaceutical Main Business Overview
13.5.5 Teva Pharmaceutical Latest Developments
13.6 Nantong Huashan Pharmaceutical
13.6.1 Nantong Huashan Pharmaceutical Company Information
13.6.2 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.6.3 Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Nantong Huashan Pharmaceutical Main Business Overview
13.6.5 Nantong Huashan Pharmaceutical Latest Developments
13.7 Teijin Pharma
13.7.1 Teijin Pharma Company Information
13.7.2 Teijin Pharma Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.7.3 Teijin Pharma Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Teijin Pharma Main Business Overview
13.7.5 Teijin Pharma Latest Developments
13.8 Kyowa Kirin
13.8.1 Kyowa Kirin Company Information
13.8.2 Kyowa Kirin Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.8.3 Kyowa Kirin Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Kyowa Kirin Main Business Overview
13.8.5 Kyowa Kirin Latest Developments
13.9 Cheplapharm Arzneimittel
13.9.1 Cheplapharm Arzneimittel Company Information
13.9.2 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.9.3 Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Cheplapharm Arzneimittel Main Business Overview
13.9.5 Cheplapharm Arzneimittel Latest Developments
13.10 Jiangsu Hengrui Pharmaceuticals
13.10.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.10.2 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.10.3 Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.10.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.11.3 Novartis Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Chongqing Yaoyou Pharmaceutical
13.12.1 Chongqing Yaoyou Pharmaceutical Company Information
13.12.2 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.12.3 Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Chongqing Yaoyou Pharmaceutical Main Business Overview
13.12.5 Chongqing Yaoyou Pharmaceutical Latest Developments
13.13 AbbVie
13.13.1 AbbVie Company Information
13.13.2 AbbVie Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.13.3 AbbVie Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AbbVie Main Business Overview
13.13.5 AbbVie Latest Developments
13.14 Hebei Renhe Yikang Pharmaceutical
13.14.1 Hebei Renhe Yikang Pharmaceutical Company Information
13.14.2 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
13.14.3 Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hebei Renhe Yikang Pharmaceutical Main Business Overview
13.14.5 Hebei Renhe Yikang Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Parathyroid Glands and Related Medicines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Parathyroid Glands and Related Medicines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Calcitriol
Table 4. Major Players of Alfacalcidol
Table 5. Major Players of Salmon Calcitonin
Table 6. Major Players of Paricalcitol
Table 7. Major Players of Other
Table 8. Global Parathyroid Glands and Related Medicines Sales by Type (2018-2023) & (K Units)
Table 9. Global Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
Table 10. Global Parathyroid Glands and Related Medicines Revenue by Type (2018-2023) & ($ million)
Table 11. Global Parathyroid Glands and Related Medicines Revenue Market Share by Type (2018-2023)
Table 12. Global Parathyroid Glands and Related Medicines Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Parathyroid Glands and Related Medicines Sales by Application (2018-2023) & (K Units)
Table 14. Global Parathyroid Glands and Related Medicines Sales Market Share by Application (2018-2023)
Table 15. Global Parathyroid Glands and Related Medicines Revenue by Application (2018-2023)
Table 16. Global Parathyroid Glands and Related Medicines Revenue Market Share by Application (2018-2023)
Table 17. Global Parathyroid Glands and Related Medicines Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Parathyroid Glands and Related Medicines Sales by Company (2018-2023) & (K Units)
Table 19. Global Parathyroid Glands and Related Medicines Sales Market Share by Company (2018-2023)
Table 20. Global Parathyroid Glands and Related Medicines Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Parathyroid Glands and Related Medicines Revenue Market Share by Company (2018-2023)
Table 22. Global Parathyroid Glands and Related Medicines Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Parathyroid Glands and Related Medicines Producing Area Distribution and Sales Area
Table 24. Players Parathyroid Glands and Related Medicines Products Offered
Table 25. Parathyroid Glands and Related Medicines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Parathyroid Glands and Related Medicines Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Parathyroid Glands and Related Medicines Sales Market Share Geographic Region (2018-2023)
Table 30. Global Parathyroid Glands and Related Medicines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Parathyroid Glands and Related Medicines Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Parathyroid Glands and Related Medicines Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Parathyroid Glands and Related Medicines Sales Market Share by Country/Region (2018-2023)
Table 34. Global Parathyroid Glands and Related Medicines Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Parathyroid Glands and Related Medicines Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Parathyroid Glands and Related Medicines Sales by Country (2018-2023) & (K Units)
Table 37. Americas Parathyroid Glands and Related Medicines Sales Market Share by Country (2018-2023)
Table 38. Americas Parathyroid Glands and Related Medicines Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Parathyroid Glands and Related Medicines Revenue Market Share by Country (2018-2023)
Table 40. Americas Parathyroid Glands and Related Medicines Sales by Type (2018-2023) & (K Units)
Table 41. Americas Parathyroid Glands and Related Medicines Sales by Application (2018-2023) & (K Units)
Table 42. APAC Parathyroid Glands and Related Medicines Sales by Region (2018-2023) & (K Units)
Table 43. APAC Parathyroid Glands and Related Medicines Sales Market Share by Region (2018-2023)
Table 44. APAC Parathyroid Glands and Related Medicines Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Parathyroid Glands and Related Medicines Revenue Market Share by Region (2018-2023)
Table 46. APAC Parathyroid Glands and Related Medicines Sales by Type (2018-2023) & (K Units)
Table 47. APAC Parathyroid Glands and Related Medicines Sales by Application (2018-2023) & (K Units)
Table 48. Europe Parathyroid Glands and Related Medicines Sales by Country (2018-2023) & (K Units)
Table 49. Europe Parathyroid Glands and Related Medicines Sales Market Share by Country (2018-2023)
Table 50. Europe Parathyroid Glands and Related Medicines Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Parathyroid Glands and Related Medicines Revenue Market Share by Country (2018-2023)
Table 52. Europe Parathyroid Glands and Related Medicines Sales by Type (2018-2023) & (K Units)
Table 53. Europe Parathyroid Glands and Related Medicines Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Parathyroid Glands and Related Medicines Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Parathyroid Glands and Related Medicines Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Parathyroid Glands and Related Medicines Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Parathyroid Glands and Related Medicines Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Parathyroid Glands and Related Medicines Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Parathyroid Glands and Related Medicines Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Parathyroid Glands and Related Medicines
Table 61. Key Market Challenges & Risks of Parathyroid Glands and Related Medicines
Table 62. Key Industry Trends of Parathyroid Glands and Related Medicines
Table 63. Parathyroid Glands and Related Medicines Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Parathyroid Glands and Related Medicines Distributors List
Table 66. Parathyroid Glands and Related Medicines Customer List
Table 67. Global Parathyroid Glands and Related Medicines Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Parathyroid Glands and Related Medicines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Parathyroid Glands and Related Medicines Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Parathyroid Glands and Related Medicines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Parathyroid Glands and Related Medicines Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Parathyroid Glands and Related Medicines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Parathyroid Glands and Related Medicines Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Parathyroid Glands and Related Medicines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Parathyroid Glands and Related Medicines Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Parathyroid Glands and Related Medicines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Parathyroid Glands and Related Medicines Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Parathyroid Glands and Related Medicines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Parathyroid Glands and Related Medicines Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Parathyroid Glands and Related Medicines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. CTTQ Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 82. CTTQ Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 83. CTTQ Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. CTTQ Main Business
Table 85. CTTQ Latest Developments
Table 86. Roche Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 87. Roche Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 88. Roche Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Roche Main Business
Table 90. Roche Latest Developments
Table 91. Future Health Pharma Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 92. Future Health Pharma Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 93. Future Health Pharma Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Future Health Pharma Main Business
Table 95. Future Health Pharma Latest Developments
Table 96. KPC Pharmaceuticals Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 97. KPC Pharmaceuticals Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 98. KPC Pharmaceuticals Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. KPC Pharmaceuticals Main Business
Table 100. KPC Pharmaceuticals Latest Developments
Table 101. Teva Pharmaceutical Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 102. Teva Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 103. Teva Pharmaceutical Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Teva Pharmaceutical Main Business
Table 105. Teva Pharmaceutical Latest Developments
Table 106. Nantong Huashan Pharmaceutical Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 107. Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 108. Nantong Huashan Pharmaceutical Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Nantong Huashan Pharmaceutical Main Business
Table 110. Nantong Huashan Pharmaceutical Latest Developments
Table 111. Teijin Pharma Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 112. Teijin Pharma Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 113. Teijin Pharma Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Teijin Pharma Main Business
Table 115. Teijin Pharma Latest Developments
Table 116. Kyowa Kirin Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 117. Kyowa Kirin Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 118. Kyowa Kirin Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. Kyowa Kirin Main Business
Table 120. Kyowa Kirin Latest Developments
Table 121. Cheplapharm Arzneimittel Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 122. Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 123. Cheplapharm Arzneimittel Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Cheplapharm Arzneimittel Main Business
Table 125. Cheplapharm Arzneimittel Latest Developments
Table 126. Jiangsu Hengrui Pharmaceuticals Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 127. Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 128. Jiangsu Hengrui Pharmaceuticals Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Jiangsu Hengrui Pharmaceuticals Main Business
Table 130. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 131. Novartis Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 133. Novartis Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Novartis Main Business
Table 135. Novartis Latest Developments
Table 136. Chongqing Yaoyou Pharmaceutical Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 137. Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 138. Chongqing Yaoyou Pharmaceutical Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Chongqing Yaoyou Pharmaceutical Main Business
Table 140. Chongqing Yaoyou Pharmaceutical Latest Developments
Table 141. AbbVie Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 142. AbbVie Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 143. AbbVie Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. AbbVie Main Business
Table 145. AbbVie Latest Developments
Table 146. Hebei Renhe Yikang Pharmaceutical Basic Information, Parathyroid Glands and Related Medicines Manufacturing Base, Sales Area and Its Competitors
Table 147. Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Product Portfolios and Specifications
Table 148. Hebei Renhe Yikang Pharmaceutical Parathyroid Glands and Related Medicines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Hebei Renhe Yikang Pharmaceutical Main Business
Table 150. Hebei Renhe Yikang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Parathyroid Glands and Related Medicines
Figure 2. Parathyroid Glands and Related Medicines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parathyroid Glands and Related Medicines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Parathyroid Glands and Related Medicines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Parathyroid Glands and Related Medicines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Calcitriol
Figure 10. Product Picture of Alfacalcidol
Figure 11. Product Picture of Salmon Calcitonin
Figure 12. Product Picture of Paricalcitol
Figure 13. Product Picture of Other
Figure 14. Global Parathyroid Glands and Related Medicines Sales Market Share by Type in 2022
Figure 15. Global Parathyroid Glands and Related Medicines Revenue Market Share by Type (2018-2023)
Figure 16. Parathyroid Glands and Related Medicines Consumed in Hospital
Figure 17. Global Parathyroid Glands and Related Medicines Market: Hospital (2018-2023) & (K Units)
Figure 18. Parathyroid Glands and Related Medicines Consumed in Clinic
Figure 19. Global Parathyroid Glands and Related Medicines Market: Clinic (2018-2023) & (K Units)
Figure 20. Parathyroid Glands and Related Medicines Consumed in Other
Figure 21. Global Parathyroid Glands and Related Medicines Market: Other (2018-2023) & (K Units)
Figure 22. Global Parathyroid Glands and Related Medicines Sales Market Share by Application (2022)
Figure 23. Global Parathyroid Glands and Related Medicines Revenue Market Share by Application in 2022
Figure 24. Parathyroid Glands and Related Medicines Sales Market by Company in 2022 (K Units)
Figure 25. Global Parathyroid Glands and Related Medicines Sales Market Share by Company in 2022
Figure 26. Parathyroid Glands and Related Medicines Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Parathyroid Glands and Related Medicines Revenue Market Share by Company in 2022
Figure 28. Global Parathyroid Glands and Related Medicines Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Parathyroid Glands and Related Medicines Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Parathyroid Glands and Related Medicines Sales 2018-2023 (K Units)
Figure 31. Americas Parathyroid Glands and Related Medicines Revenue 2018-2023 ($ Millions)
Figure 32. APAC Parathyroid Glands and Related Medicines Sales 2018-2023 (K Units)
Figure 33. APAC Parathyroid Glands and Related Medicines Revenue 2018-2023 ($ Millions)
Figure 34. Europe Parathyroid Glands and Related Medicines Sales 2018-2023 (K Units)
Figure 35. Europe Parathyroid Glands and Related Medicines Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Parathyroid Glands and Related Medicines Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Parathyroid Glands and Related Medicines Revenue 2018-2023 ($ Millions)
Figure 38. Americas Parathyroid Glands and Related Medicines Sales Market Share by Country in 2022
Figure 39. Americas Parathyroid Glands and Related Medicines Revenue Market Share by Country in 2022
Figure 40. Americas Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
Figure 41. Americas Parathyroid Glands and Related Medicines Sales Market Share by Application (2018-2023)
Figure 42. United States Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Parathyroid Glands and Related Medicines Sales Market Share by Region in 2022
Figure 47. APAC Parathyroid Glands and Related Medicines Revenue Market Share by Regions in 2022
Figure 48. APAC Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
Figure 49. APAC Parathyroid Glands and Related Medicines Sales Market Share by Application (2018-2023)
Figure 50. China Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Parathyroid Glands and Related Medicines Sales Market Share by Country in 2022
Figure 58. Europe Parathyroid Glands and Related Medicines Revenue Market Share by Country in 2022
Figure 59. Europe Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
Figure 60. Europe Parathyroid Glands and Related Medicines Sales Market Share by Application (2018-2023)
Figure 61. Germany Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Parathyroid Glands and Related Medicines Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Parathyroid Glands and Related Medicines Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Parathyroid Glands and Related Medicines Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Parathyroid Glands and Related Medicines Sales Market Share by Application (2018-2023)
Figure 70. Egypt Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Parathyroid Glands and Related Medicines Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Parathyroid Glands and Related Medicines in 2022
Figure 76. Manufacturing Process Analysis of Parathyroid Glands and Related Medicines
Figure 77. Industry Chain Structure of Parathyroid Glands and Related Medicines
Figure 78. Channels of Distribution
Figure 79. Global Parathyroid Glands and Related Medicines Sales Market Forecast by Region (2024-2029)
Figure 80. Global Parathyroid Glands and Related Medicines Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Parathyroid Glands and Related Medicines Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Parathyroid Glands and Related Medicines Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Parathyroid Glands and Related Medicines Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Parathyroid Glands and Related Medicines Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の副甲状腺及び関連医薬品市場予測 2023年-2029年] (コード：LP23DC02777)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の副甲状腺及び関連医薬品市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の副甲状腺疾患治療市場予測 2023年-2029年
  • 世界の5-フルオシトシン医薬品市場予測 2023年-2029年
  • 世界の5-フルオシトシン医薬品市場予測 2023年-2029年
  • 世界の糖尿病用経口薬市場予測 2023年-2029年
  • 世界のゾレドロン酸溶液市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆